RETRACTION: PRMT5 Participates in B Cell Overactivation in Patients With Primary Sjogren's Syndrome (pSS) Through RSAD2‐Mediated NF‐κB Signaling

Documenti analoghi

• Kaempferitrin Attenuates Lipopolysaccharide‐Induced Cardiac Dysfunction Through Suppression of the NF‐κB/NLRP3 Signaling Pathway
  di: Hongyu Kuang, et al.
  Pubblicazione: (2026)
• Albiflorin Relieves Intervertebral Disc Degeneration Through Inhibiting Nucleus Pulposus Cell via the p38 MAPK/NF‐κB Pathway
  di: Kai Yang, et al.
  Pubblicazione: (2026)
• DEL‐1 Protects the Myocardium From Ischemia/Hypoxia Injury Through Regulating the Sirt1/NF‐κB Signaling Pathway
  di: Bin Hu, et al.
  Pubblicazione: (2025)
• RETRACTION: HDAC4 Depletion Ameliorates IL‐13‐Triggered Inflammatory Response and Mucus Production in Nasal Epithelial Cells via Activation of SIRT1/NF‐κB Signaling
  Pubblicazione: (2026)
• Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway
  di: Lili Tang, et al.
  Pubblicazione: (2025)